FLT3LG and neoplasm: The administration of TK/Flt3L via adenoviral vectors in murine models harboring brainstem gliomas led to the induction of potent antitumor immune responses, characterized by the infiltration of tumor-specific T lymphocytes and a notable extension in the median survival of the experimental subjects.